Patient Access: Early Access, Compassionate Use, Off-label Use
This seminar provides information on early access programmes, HTA requirements, CUP and off-label use in Europe
-
This seminar provides information on early access programmes, HTA requirements, CUP and off-label use in Europe50.108333 8.6672348
| Wann |
30.06.2020 von 09:00 bis 17:00 |
|---|---|
| Veranstaltungsort | Mercure Hotel Kaiserhof Frankfurt City Center |
| Stadt | Frankfurt |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500-680 |
| Zielgruppe |
This seminar is intended for workers in the healthcare industry responsible for market access, healthcare management and, in particular, patient access programmes. |
| Termin übernehmen |
vCal
iCal
|
Seminar goal:
This seminar addresses the various options for fast access to innovative medicines in Europe, the reimbursement options and the mechanisms of compounding and off-label use.
Topics:
- Patient access to orphan drugs and high-price therapies
- Early access schemes in Europe: Are they reimbursed?
- Pricing considerations
- Compassionate use programmes in Europe
- Compounding, off-label use and hospital exemption
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
Programm
2006235.pdf
—
PDF document,
308 kB (315,774 bytes)
